FDA internal review points to imminent Pfizer/BioNTech EUA, spotlights potential for single-dose vaccination
Pfizer and BioNTech have cleared one of the last hurdles en route to the first Covid-19 vaccine authorization.
On Tuesday, the FDA released its own …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
